MONZA ARES invests over €5 million in advanced technologies for integrated cardiovascular diagnosis and treatment
MONZA ARES, Romania’s largest private cardiology network, is investing over €5 million in an integrated ecosystem for cardiovascular diagnosis and treatment, strengthening its position as a regional leader in precision medicine. The investment includes cutting-edge imaging, minimally invasive surgery, and interventional technologies, making it one of the few centers in Central and Eastern Europe with a fully integrated chain from high-resolution imaging to robotic-assisted surgery.
The new development phase introduces three key systems: the Revolution Vibe CT from GE Healthcare – the first of its kind installed in Romania, the DaVinci surgical robot, and the Azurion 7 angiography system by Philips. These acquisitions will enable faster diagnoses, safer procedures, and shorter recovery times for patients.
“This investment is not just about equipment; it completes a complex medical ecosystem. We combine multidisciplinary expertise with state-of-the-art technology to provide patients with rapid diagnosis, safe treatment, and personalized recovery,” said Dr. Geanina Durigu, CEO of MONZA ARES.
The Revolution Vibe CT enables full-heart scans in a single rotation, delivering crystal-clear images even for patients with irregular heart rhythms. Featuring a 512-slice configuration and AI image optimization, it ensures high precision with reduced radiation and contrast exposure.
The DaVinci surgical robot will be used for thoracic, general, urological, and selected cardiovascular interventions. It allows for smaller incisions, enhanced visualization, and increased precision, contributing to faster recovery and reduced risk of complications.
Finally, the Azurion 7 angiography system by Philips, featuring the R3.0 platform, improves control, workflow efficiency, and visualization during complex procedures in cardiology, neurology, and oncology.
With this strategic investment, MONZA ARES reinforces its commitment to innovation and excellence in cardiovascular medicine.



